News
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...
Rising Competition: Hims & Hers operates in a competitive digital health landscape, facing rivals like Teladoc, Ro and Amazon Pharmacy. These competitors leverage similar direct-to-consumer models ...
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Today is a big day in drugs. It’s when the US Food and Drug Administration shuts down an emergency measure that allows pharmacies to sell copies of the most widely prescribed weight-loss injection.
It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...
WeightWatchers recently filed for bankruptcy. Part of the reason is because it couldn't adapt fast enough to a rapidly ...
Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.
The implications of your question trouble me. Do you think your husband is not entitled to self-pleasure? Would you be ...
4d
Zacks Investment Research on MSNHere's Why You Should Add Hims & Hers Stock to Your Portfolio NowHims & Hers Health HIMS is well-positioned for growth as it addresses a vast unmet healthcare market, leveraging a total ...
3d
NewsNation on MSNHow to get weight loss drugs without insuranceWhile weight loss medications are usually not covered by insurance, there are other ways to secure a medication without a provider. There are 13 states whose Medicaid programs allow for GLP-1 drugs to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results